SCHEMBL21846319

SCHEMBL21846319

C=CC(=O)N1CCN(c2nc(OCCCCC)nc(C)c2CC)C[C@@H]1CC#N

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.46
▸ SOS1 Q07889 6/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21912203 0.91 KRAS (0.43) KRASSOS1
SCHEMBL21846309 0.91 KRAS (0.47) KRASSOS1
SCHEMBL21846316 0.84 KRAS (0.62) KRASSOS1
SCHEMBL21896284 0.81 KRAS (0.40) KRAS
SCHEMBL19637810 0.75 — —
SCHEMBL21846390 0.73 KRAS (0.46) KRASSOS1
SCHEMBL21895605 0.70 KRAS (0.43) KRAS
SCHEMBL21734112 0.70 KRAS (0.55) KRASSOS1
SCHEMBL21895629 0.69 KRAS (0.38) KRAS
SCHEMBL19617678 0.68 KRAS (0.77) KRASSOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055755-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
WO-2020055760-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback